Biohaven Ltd. (BHVN) stock
BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
$13.24−0.56 (-4.06%)
Close on Nov 17, 2026Market cap $2.00BP/E –Yield –
Biohaven total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Biohaven's total debt was $264.29M at Sep 30, 2026. For fiscal 2025 it was $238.90M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $238.90M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $264.29M | -1.5% |
| Q2 FY2026 | Jun 30, 2026 | $259.48M | +0.9% |
| Q1 FY2026 | Mar 31, 2026 | $241.91M | – |
| Q4 FY2025 | Dec 31, 2025 | $238.90M | – |
| Q3 FY2025 | Sep 30, 2025 | $268.27M | – |
| Q2 FY2025 | Jun 30, 2025 | $257.07M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
See a number that looks wrong?